Drug Research
Inizio Launch Elevate Set to Help Global Pharma Maximize Product Launch Potential
Market-leading commercialization platform, Inizio, has announced ‘Inizio Launch Elevate’, a connected suite of its best-in-class capabilities designed to accelerate and simplify product launches for global pharma and biotech companies.
Inizio Launch Elevate combines deep market and patient insights, launch strategy...
Drug Research
Greenphire and Florence Healthcare Announce Technology Partnership
Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, and Florence Healthcare, the leading site enablement platform used by 18,000 connected research sites in 55 countries, announce a technology partnership that integrates two of...
Drug Research
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Charles River Laboratories International, Inc. and Aitia, a leader in the application of Causal AI and Digital Twins announced a strategic agreement that gives Aitia access to Logica™, Charles River's Artificial Intelligence (AI) powered drug solution platform, for the...
Drug Research
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates
Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-generation bioconjugates.
Under the terms of the collaboration,...
Drug Research
Novartis Enters into Deal with Legend Biotech for $100 Million Upfront
Legend Biotech has secured an exclusive global license deal with Novartis giving the Swiss pharma access to Legend’s CAR-T cell therapies.
The deal will give Novartis access to CAR-Ts that target the delta-like ligand protein (DLL3) candidate LB2102, which Legend...
Drug Research
Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies.
The collaboration was established...
Drug Research
New Pharma Legislation May Cut Europe R&D Share By One-Third
The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a newly published assessment, EFPIA infers that the draft proposals would further speed up the decline...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read